Immune Regulation News Volume 2.46 | Dec 3 2010

    By
    Justin.choi
    -
    0
    145

    Immune Regulation News 2.46, December 3, 2010.
    In this issue: Science News  |  Current Publications  |  Industry News  |  Policy News  |  EventsSubscribe  |  Unsubscribe

    TOP STORY

    Hes1 Is a Critical but Context-Dependent Mediator of Canonical Notch Signaling in Lymphocyte Development and Transformation  ShareThis
    Researchers showed here that conditional inactivation of Hes1 , a well-characterized Notch target gene, in adult murine bone marrow cells severely impaired T cell development without affecting other Notch-dependent hematopoietic lineages such as marginal zone B cells. [Immunity]

    MultipleMyeloma_645x110_V01

    SPECIAL FEATURE

    Interested in recruiting talented individuals? Post your career opportunities in Immune Regulation News at no cost. Contact us at info@connexoncreative.com

    Twitter Follow us on Twitter! @Immune_News

    SCIENCE NEWS

    Journal of Experimental Medicine Publishes New Dynavax Findings on the Role of TLRS in Cutaneous Lupus
    Dynavax Technologies Corporation reported new data that suggests an important role of the key innate immune receptors TLR7 and TLR9 in cutaneous lupus and related skin conditions. [Press release from the Dynavax Technologies Corporation discussing online prepublication in the Journal of Experimental Medicine]

    Mayo Researchers Find Drug-Resistant HIV Patients With Unimpaired Immune Cells
    Researchers have shown why, in a minority of HIV patients, immune function improves despite a lack of response to standard anti-retroviral treatment. In these cases, researchers say, the virus has lost its ability to kill immune cells. [Press release from the Mayo Clinic discussing online prepublication in PLoS Pathogens]

    Adipose Tissue Produces Cells Involved in Immune Response
    Researchers isolated a population of hematopoietic stem cells in adipose tissue capable of differentiating into mast cells. [Press release from PhysOrg discussing online prepublication in Stem Cells]

    CellFrequenciesWallchart_645x110

    CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

    Autoimmune Skin Inflammation is Dependent on Plasmacytoid Dendritic Cell Activation by Nucleic Acids via TLR7 and TLR9
    Recognition of endogenous DNA and RNA by cells expressing TLR7 and TLR9 is an important contributor to the pathogenesis of systemic lupus erythematosus and has been suggested to contribute to cutaneous lupus and to a group of related inflammatory skin diseases termed interface dermatitis. Researchers have developed a mouse model of TLR7- and TLR9-dependent skin inflammation using tape stripping. [J Exp Med]

    IL-27 Supports Germinal Center Function by Enhancing IL-21 Production and the Function of T Follicular Helper Cells
    Researchers show that the heterodimeric cytokine IL-27 is critical for the function of T follicular helper cells and for normal and pathogenic germinal center responses. [J Exp Med]

    Blockade of Osteopontin Reduces Alloreactive CD8+ T Cell-Mediated Graft-Versus-Host Disease
    This study demonstrates for the first time, the critical effect of osteopontin (OPN) in the initiation and persistence of CD8+ T cell-mediated graft-versus-host disease (GVHD), and validates OPN as a potential target in GVHD prevention. [Blood]

    Inflammation-Induced Tumorigenesis in the Colon is Regulated by Caspase-1 and NLRC4
    Using the azoxymethane and dextran sodium sulfate colitis-associated colorectal cancer model, researchers show that caspase-1-deficient (Casp1-/-) mice have enhanced tumor formation. [Proc Natl Acad Sci USA]

    Adipose Tissue as a Dedicated Reservoir of Functional Mast Cell Progenitors
    In this study, researchers asked whether mast cells present in mice adipose tissue could derive from hematopoietic stem/progenitor cells identified in the tissue. [Stem Cells]

    Patients with Discordant Responses to Antiretroviral Therapy Have Impaired Killing of HIV-Infected T Cells
    Researchers have studied the circumstance of HIV-infected patients in whom antiretroviral therapy results in immunologic benefit, despite virologic failure. [PLoS Pathog]

    INDUSTRY NEWS

    Hycult Biotech B.V. Announces Formation of Hycult Biotech Inc. to Serve the Innate Immune Market Segment in the Americas
    Hycult Biotechnology bv announced the formation of Hycult Biotech Inc. a wholly owned subsidiary located in Plymouth Meeting, PA. The Company specializes in the development, manufacture and commercialization of antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields. [Hycult Biotech B.V. Press Release]

    Immune Response Modifiers from 3M Available for the Pharmaceutical Industry
    3M announces the availability of immune response modifier compounds for nonvaccine use in the pharmaceutical industry. The toll-like receptor (TLR) compounds, that activate through TLR7 and TLR8, show promise for the treatment of conditions including cancer, dermatologic diseases and atopic diseases, such as allergy and asthma. [Businesswire]

    POLICY NEWS

    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

    EVENTS (Listed by Date)

    5th Annual Stem Cell Meeting on the Mesa
    December 7, 2010
    La Jolla, United States

    Safety Symposium organized by the NIH RAC and Co-hosted by CliniGene: Retroviral and Lentiviral Vectors for Long-Term Gene Correction: Clinical Challenges in Vector and Trial Design
    December 9-10, 2010
    Bethesda, United States

    The 50th Midwinter Conference of Immunologists at Asilomar
    January 22-25, 2011
    Pacific Grove, United States

    Phacilitate 7th Annual Cell & Gene Therapy Forum 2011
    January 24-26, 2011
    Washington, D.C., United States

    Phacilitate 9th Annual North American Vaccine Forum
    January 24-26, 2011
    Washington, D.C., United States

    AACR-ACS Joint Meeting on Chemistry in Cancer Research: The Biological Chemistry of Inflammation as a Cause of Cancer
    January 30-February 2, 2011
    San Diego, United States

    Keystone Symposia: Dendritic Cells and the Initiation of Adaptive Immunity
    February 12-17, 2011
    Santa Fe, United States

    Keystone Symposia: Genetics, Immunology and Repair in Multiple Sclerosis
    February 15-20, 2011
    Taos, United States

    Lorne Infection and Immunity Conference 2011
    February 16-18, 2011
    Lorne, Australia

    18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
    February 27-March 2, 2011
    Boston, United States

    NEW  Cell Culture World Congress 2011 – Optimising Cell Culture Development for Biopharmaceutical, Bioprocessing and Manufacture
    February 28-March 2, 2011
    Munich, Germany

    NEW PITTCON Conference & Expo 2011
    March 13-18, 2011
    Atlanta, United States

    The 6th International Conference on Oncolytic Viruses as Cancer Therapeutics
    March 16-19, 2011
    Las Vegas, United States

    2011 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting
    March 18-22, 2011
    San Francisco, United States

    Microbiota and Mucosal Immunology: The Interface in Health and Disease
    April 14-16, 2011
    San Francisco, United States

    GTCbio 2nd International Conference on Cancer Immunotherapy & Immunomonitoring
    May 2-5, 2011
    Budapest, Hungary

    NEW  World Stem Cells & Regenerative Medicine Congress 2011
    May 9-11, 2011
    London, United Kingdom

    American Society of Gene and Cell Therapy (ASGCT) 14th Annual Meeting
    May 18-22, 2011
    Seattle, United States

    Gordon Research Conference: Viruses & Cells
    May 29-June 3, 2011
    Lucca (Barga), Italy

    DNA Vaccines 2011
    July 12-14, 2011
    San Diego, United States

    Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.


    JOB OPPORTUNITIES

    Lab Technologist – Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies)

    Lab Technologist – Tissue Culture (STEMCELL Technologies)

    Product Manager – Pluripotent Stem Cells (STEMCELL Technologies)

    Recruit Top Talent
    Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News at no cost.

    Visit here to post your career opportunities.


    Have we missed an important article or publication in Immune Regulation News? Click here to submit!



    Comments or Suggestions? Email info@connexoncreative.com with your feedback.


    Learn more about Immune Regulation News: Archives  |  Events  |  Subscribe  |  Contact Us